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To determine the postantibiotic effect of aminoglycosides, two methods are currently being used to remove
the test drug: repeated washing and dilution. An enzymatic inactivation method of removing gentamicin and
tobramycin was developed and compared with the dilution method. This enzymatic method provides a rapid
and simple alternative method of removing aminoglycosides which results in reliable postantibiotic-effect
values.
Three factors are relevant when determining aminoglycoside
dosing schedules: MIC, the kinetics of bactericidal activity, and
the postantibiotic effect (PAE) (10). The PAE can be deter-
mined in various ways, for example, by counting viable organ-
isms, by measuring impedance or bioluminescence, by spectro-
photometry, and by examining morphology (7). An important
step in measuring the PAE is the rapid removal of antibiotic
after a short exposure of the bacteria to the drug. In general,
three methods of removing the antibiotic have been described:
dilution, repeated washing, and enzymatic inactivation (2). A
specific problem in measuring the PAE of aminoglycosides is
the marked killing capacity of these antibiotics, particularly at
high concentrations, necessitating a substantial dilution (up to
1,000-fold) to eliminate antimicrobial activity. As a result, the
number of viable bacteria in the sample falls below the limit of
detection (4). The second method used for removal of amin-
oglycosides is repeated washing. Although this method does
not influence the limit of detection, washing itself may cause a
temporary reduction in the rate of bacterial regrowth (2, 9),
possibly resulting in less reliable PAE values. In addition,
washing is time-consuming. The third method used for antibi-
otic removal is enzymatic drug inactivation. So far, the use of
this method has been restricted to the b-lactam antibiotics. In
the present study, an enzymatic method was developed for
inactivation of the aminoglycosides gentamicin and tobramy-
cin. To validate this new method, we compared the results of
the enzymatic inactivation method with those of the generally
used dilution method.
The strains used for measurement of the PAE by the enzy-
matic inactivation method were Staphylococcus aureus ATCC
29213, Escherichia coli ATCC 25922, Klebsiella pneumoniae
ATCC 43816, and Pseudomonas aeruginosa ATCC 27853.
MICs were determined by a standard macrodilution method
with Mueller-Hinton broth (Difco, Amsterdam, The Nether-
lands) supplemented with Ca21 (25 mg/l) and Mg21 (12.5
mg/l) (MHBS) (8). The MICs of gentamicin and tobramycin
for the strains tested were 1.0 and 0.5 mg/l for S. aureus, 1.0
and 1.0 mg/l for E. coli, 0.5 and 0.5 mg/l for K. pneumoniae, and
1.0 and 0.5 mg/l for P. aeruginosa, respectively. E. coli R 176 (a
clinical isolate of unknown source, resistant to gentamicin and
tobramycin and susceptible to netilmicin and amikacin) was
used for the extraction of an aminoglycoside-acetylating en-
zyme [AAC(3)-II] (6). E. coli R 176 was inoculated from a
fresh overnight culture into Todd-Hewitt broth (Oxoid, Bas-
ingstoke, Hampshire, England) containing either gentamicin
(5 mg/l; Schering-Plough, Amstelveen, The Netherlands) or
tobramycin (5 mg/l; Eli Lilly and Company, Nieuwegein, The
Netherlands) and incubated with shaking (200 rpm) at 378C
until the optical density at 660 nm was 0.63. After centrifuga-
tion (15 min at 6,000 3 g and 48C), the pellets were resus-
pended in phosphate-buffered saline and the bacteria were
disrupted by ultrasonic treatment at an amplitude of 14 (So-
niprep; MSE, Bughborough/Leics, Great Britain) 10 times for
10 s each with cooling on ice for 10 s between treatments. The
cell debris was then centrifuged for 2 h at 100,000 3 g (L-70
centrifuge; Beckman, Palo Alto, Calif.). After the addition of
dithiothreitol (Sigma, St. Louis, Mo.) to a final concentration
of 5 mM, the supernatant was filtered (0.45-mm-pore-size fil-
ter; Schleicher and Schuell, ’s-Hertogenbosch, The Nether-
lands) and stored as a stock solution at 2808C. The number of
units of activity in the enzyme preparation was determined in
tobramycin solutions of 10 and 20 mg/l in MHBS at 378C.
There was no difference in the initial rates of enzyme activity
measured at both tobramycin concentrations (data not shown).
The enzymatic activity was further determined under several
sets of environmental conditions: four tobramycin solutions of
5 mg/l were made in MHBS at pH 7.2 (method 1), MHBS from
a 24-h culture of S. aureus at an adjusted pH of 7.2 (method 2),
MHBS from a 24-h culture of S. aureus at pH 5.3 (method 3),
and MHBS from a logarithmic culture of S. aureus at pH 7.2,
exposed for 1 h to 5 mg of tobramycin per liter (method 4). To
each solution were added 0.02 U of enzyme and 0.2 mmol of
acetyl coenzyme A, and the solutions were incubated in a water
bath at 378C with shaking (200 rpm). Samples were taken at
time zero, 10 s, 1 min, and 5 min and immediately heated to
908C to inactivate the enzymes. Tobramycin concentrations
were determined by a standard microbiological agar diffusion
test, with S. aureus ATCC 29213 as a test strain. The enzymatic
activity of the stock solution stored at 2808C was tested every
month.
In order to detect a possible influence of the enzyme and
acetyl coenzyme A on the bacterial growth rate, growth curves
were determined by a standard method (1). Briefly, a logarith-
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mic culture of each strain, with an inoculum of approximately
5 3 105 CFU/ml, was incubated with 0.01 U of enzyme per ml
and 0.2 mmol of acetyl coenzyme A (95%, prepared enzymat-
ically; Sigma) per ml. Samples were taken at 0, 1, 2, 3, 4, 6, and
24 h. Control growth curves were obtained similarly, but the
enzyme and acetyl coenzyme A were not added to the cultures.
To determine the PAE, a logarithmic culture of approxi-
mately 5 3 106 CFU/ml in MHBS was exposed to gentamicin
or tobramycin at a concentration of four times the MIC for 1
h at 378C. After the incubation period, the antibiotic was re-
moved by two methods: 500-fold dilution in prewarmed MHBS
(2) and enzymatic inactivation. For enzymatic inactivation,
0.01 U of enzyme per ml and 0.2 mmol of acetyl coenzyme A
per ml were added to the samples. The control cultures, which
were not exposed to the antibiotics, were treated similarly. The
cultures were further incubated for 6 h at 378C. Samples were
taken each hour and diluted serially 10-fold in cold sterile
saline on ice. Each dilution was plated on tryptone soy agar
(Oxoid) and incubated overnight at 378C. To decrease the
variability at low colony counts, near the lower limit of detec-
tion, 20-ml samples were taken from the cultures at 0, 1, 2, and
3 h, treated by the dilution method, and filtered with the
Sensor II Milliflex-100 system (0.45-mm-pore-size filter; Milli-
pore Corporation, Bedford, Mass.). At 4 to 6 h, 1-ml samples
were plated on tryptone soy agar and incubated overnight at
378C. Each experiment was performed six times. The PAE was
defined as described by Craig and Gudmundsson (2) as T 2 C,
where T is the time required for the CFU count of the antibi-
otic-exposed culture to increase 1 log10 unit above the count
immediately after drug removal and C is the corresponding
time for the control cultures. The SAS computer package was
used for statistical analysis (11).
Extraction of enzyme from 1 liter of bacterial culture yielded
90 ml of a solution containing 0.1 U of enzyme per ml (stan-
dard deviation5 0.01, n5 3). Figure 1, a plot of the enzymatic
activities under several sets of environmental conditions, shows
no differences among the enzymatic activities in MHBS at pH
7.2 (method 1), in MHBS from a 24-h culture of S. aureus at an
adjusted pH of 7.2 (method 2), and in MHBS from a logarith-
mic culture of S. aureus at pH 7.2 (method 4). The enzymes
were almost inactive in MHBS containing a 24-h culture of S.
aureus at pH 5.3 (method 3). The results show that the enzy-
matic solution was able to inactivate the tobramycin under
several test conditions, including the simulation of the PAE
test conditions (method 4). The enzymatic stock solution
stored at 2808C was stable for at least 2 years.
No significant differences were found between the growth
curves of the strains in the presence or in the absence of the
enzyme and acetyl coenzyme A (data not shown). The mean
PAE values determined by the dilution and enzymatic inacti-
vation methods are shown in Table 1. The difference between
the results of the two methods is expressed as the mean change
in PAE (DPAE 5 PAEdilution 2 PAEenzyme for each individual
pair of experiments) with 95% confidence intervals. There was
no significant difference between the values determined by the
two methods. The observed aminoglycoside PAEs for both
methods were highly comparable, and differences were not
statistically significant. The between-sample, between-day vari-
abilities of the PAE values, expressed as the mean coefficient
of variation of each of the four strains, were 7.5% (gentamicin)
and 9.3% (tobramycin) for the dilution method and 8.3% (gen-
tamicin) and 9.2% (tobramycin) for the enzymatic inactivation
method.
The PAE has been used to support the use of alternative
dosing schedules, i.e., larger doses with longer intervals (5, 12).
Because of the supposed significance of the PAE, the method
for measuring the PAE has to be as accurate as possible. There
was no significant difference in PAE values determined by the
above-described enzymatic inactivation method and the dilu-
tion method at a concentration of four times the MIC. In
addition, the PAE values found were comparable to those
mentioned in the literature (2, 3). An important drawback of
FIG. 1. Enzymatic activity, shown as the removal of tobramycin over time
under different environmental conditions, i.e., in MHBS at pH 7.2 (h), in MHBS
from a 24-h culture of S. aureus at pH 5.3 (}), in MHBS from a 24-h overnight
culture of S. aureus at an adjusted pH of 7.2 (), and in MHBS from a loga-
rithmic culture of S. aureus at pH 7.2, exposed for 1 h to a 5-mg/l tobramycin
solution (E) (simulating PAE test conditions). Data are means 6 standard
deviations from four experiments.
TABLE 1. In vitro PAEs obtained for gentamicin and tobramycin by dilution and enzymatic inactivation
Strain
Gentamicin Tobramycin
PAEa (h)
DPAEb
PAEa (h)
DPAEb
Dilution Enzymaticinactivation Dilution
Enzymatic
inactivation
S. aureus ATCC 29213 2.4 (0.1) 2.5 (0.1) 20.1 (20.30–0.04) 2.0 (0.3) 2.0 (0.2) 0.0 (20.33–0.26)
E. coli ATCC 25922 1.6 (0.2) 1.5 (0.2) 0.1 (20.04–0.18) 1.6 (0.1) 1.6 (0.2) 0.0 (20.29–0.22)
K. pneumoniae ATCC 43816 2.1 (0.1) 2.1 (0.2) 0.0 (20.23–0.13) 2.2 (0.1) 2.2 (0.2) 0.0 (20.29–0.29)
P. aeruginosa ATCC 27853 1.9 (0.1) 1.9 (0.1) 0.0 (20.30–0.17) 2.1 (0.1) 2.0 (0.1) 0.1 (20.10–0.23)
Overall 0.0 (20.12–0.03) 0.0 (20.10–0.10)
a Data are mean PAEs after a 1-h exposure to four times the MICs of the antibiotics, based on six experiments. Values in parentheses are standard deviations.
b Data are mean differences in PAEs obtained by the dilution and the enzymatic inactivation methods in paired parallel experiments. Values in parentheses are 95%
confidence intervals.
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the dilution method is the relatively high limit of detection, and
in order to get reliable colony counts, a large sample must be
filtered because of the 500-fold dilution. In contrast, with the
enzymatic inactivation method, no problems were encountered
with respect to the limit of detection.
We conclude that the enzymatic inactivation method is a
simple, rapid, and more accurate method of measuring the
PAEs of gentamicin and tobramycin, especially at high con-
centrations. With the appropriate enzymes, the same method
should be applicable for the study of PAEs of other aminogly-
cosides.
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